Form 8-K - Current report:
SEC Accession No. 0001213900-26-026174
Filing Date
2026-03-11
Accepted
2026-03-11 16:24:30
Documents
12
Period of Report
2026-03-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea028113901-8k_biomx.htm   iXBRL 8-K 25738
  Complete submission text file 0001213900-26-026174.txt   190499

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phge-20260311.xsd EX-101.SCH 3005
3 XBRL LABEL FILE phge-20260311_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE phge-20260311_pre.xml EX-101.PRE 22352
14 EXTRACTED XBRL INSTANCE DOCUMENT ea028113901-8k_biomx_htm.xml XML 3202
Mailing Address 850 NEW BURTON ROAD SUITE 201 DOVER DE 19904
Business Address 850 NEW BURTON ROAD SUITE 201 DOVER DE 19904 972 545610935
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

EIN.: 823364020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 26743730
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)